The Weight-Loss Gold Rush: Why All Eyes Are On Viking Therapeutics After a Hefty Biotech Deal
Mounjaro vs. Ozempic: Unpacking the GLP-1 Showdown for Weight Loss Dominance
Viking Therapeutics' Oral Weight Loss Drug Stumbles: VK2735 Data Leaves Investors Underwhelmed